The early and timely introduction of radiofrequency ablation technology, when an effective alternative for tumor surgery was required has been the prime reason for its dominance in the tumor ablation therapy market. The overall market opportunity for Tumor ablation therapy is expected to surpass US$ 1.2 Billion by 2023.
The high success rate of tumor ablation has been one of the promoting factors of the novel therapeutic, thus making it one of the most preferable tumor therapies where other therapeutics might not be feasible for multiple reasons. The tumor ablation technique has been used for the treatment of various types of cancer such as liver cancer, lung cancer, prostate cancer, colorectal cancer etc.
Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
The ongoing technical innovations have made tumor ablation procedure safe and painless with impressive results during and after treatment. With rising awareness in the healthcare industry all over the world, cancer ablation is steadily getting popular as one of the most preferred method of cancer therapy for various types of cancer. Hospitals and healthcare centers realize the immense potential that cancer ablation therapy has, thus providing the facility to their patients which would further help in promoting the therapeutic.
Read the full report: https://www.reportlinker.com/p05103455
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
SOURCE Reportlinker
Back to HCB News
